Name | HY-Lysostaphin |
CAS | 9011-93-2 |
MW | ≈27.0KDa |
Source | Recombinant expression in E.coli |
Protein purity | >98%(SDS-PAGE detection) |
Product application | Biological bacteriostatic agent; Disinfectant, medical device development. etc. |
Lysostaphin is a peptidase produced by Staphylococcus simulans and was separated in 1960 by Schindler and Schuhardt. Lysostaphin is synthesized as a preproenzyme of 42,000 Da with a signal peptide that is cleaved intracellularly and an N-terminal propeptide removed extracellularly to yield the mature 27-kDa enzyme. The sequence element that is responsible for binding to the cell wall of Staphylococcus aureus is at the C-terminus of the molecule .
Lysostaphin cleaves staphylococcal peptidoglycans in general but is directed specifically to S.aureus target cells. In lysing staphylococci, the key enzymatic reaction of lysostaphin is the specific cleavage of the Gly-Gly bond in the pentaglycine subunit of the cell wall peptidoglycan and lyses cells in all metabolic states .